RecruitingNCT06809868

Role of Transposable Elements in Septic Immune Aging


Sponsor

University of California, San Francisco

Enrollment

116 participants

Start Date

Feb 14, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to learn about how transposable element levels affect the patient outcomes in sepsis. The main questions it aims to answer is: 1. Do transposable elements prematurely age the immune systems of patients with sepsis? 2. Do transposable elements correlate with increased mortality in patients with sepsis in the ICU? 3. Do transposable elements correlate with increased amount of secondary infections in patients with sepsis in the ICU? Participants will have blood drawn from them but will not be subjected to additional interventions.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Age 18 or older
  • Admitted to ICU with sepsis (Sepsis 3 Criteria)
  • SOFA score of at least 2 at time of enrollment

Exclusion Criteria7

  • Patients on organ transplantation immunosuppression
  • Patients with preexisting leukopenia
  • Cancer patients receiving CAR-T therapy
  • Patients who are under 18 years of age or otherwise deemed pediatric
  • Patients with an ongoing bleeding diathesis (ie: DIC, hemorrhagic shock)
  • Patients with a chronic hemoglobin below 7.0
  • Patients who, prior to their ICU admission, are blood transfusion dependent

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

GENETICRNA and DNA Sequencing

DNA and RNA sequencing will be conducted on both control participants and patients with sepsis who are admitted to the ICU.


Locations(1)

University of California, San Francisco

San Francisco, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06809868


Related Trials